BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 2249621)

  • 1. Glucose transporter in insulin sensitive tissues of lean and obese mice. Effect of the thermogenic agent BRL 26830A.
    Le Marchand-Brustel Y; Olichon-Berthe C; Grémeaux T; Tanti JF; Rochet N; Van Obberghen E
    Endocrinology; 1990 Dec; 127(6):2687-95. PubMed ID: 2249621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a thermogenic agent, BRL 26830A, on insulin receptors in obese mice.
    Rochet N; Tanti JF; Grémeaux T; Van Obberghen E; Le Marchand-Brustel Y
    Am J Physiol; 1988 Aug; 255(2 Pt 1):E101-9. PubMed ID: 2841863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased glucose transporter (GLUT 4) content in insulin-sensitive tissues of obese aurothioglucose- and monosodium glutamate-treated mice.
    Machado UF; Shimizu Y; Saito M
    Horm Metab Res; 1993 Sep; 25(9):462-5. PubMed ID: 8225198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of novel beta-adrenoceptor agonists on carbohydrate metabolism: relevance for the treatment of non-insulin-dependent diabetes.
    Cawthorne MA; Carroll MJ; Levy AL; Lister CA; Sennitt MV; Smith SA; Young P
    Int J Obes; 1984; 8 Suppl 1():93-102. PubMed ID: 6152558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of obesity with thermogenic beta-adrenoceptor agonists: studies on BRL 26830A in rodents.
    Arch JR; Ainsworth AT; Ellis RD; Piercy V; Thody VE; Thurlby PL; Wilson C; Wilson S; Young P
    Int J Obes; 1984; 8 Suppl 1():1-11. PubMed ID: 6152555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
    Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM
    Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental regulation of GLUT-1 (erythroid/Hep G2) and GLUT-4 (muscle/fat) glucose transporter expression in rat heart, skeletal muscle, and brown adipose tissue.
    Santalucía T; Camps M; Castelló A; Muñoz P; Nuel A; Testar X; Palacin M; Zorzano A
    Endocrinology; 1992 Feb; 130(2):837-46. PubMed ID: 1370797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cold acclimation on the expression of glucose transporter Glut 4.
    Olichon-Berthe C; Van Obberghen E; Le Marchand-Brustel Y
    Mol Cell Endocrinol; 1992 Nov; 89(1-2):11-8. PubMed ID: 1301380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling.
    Young PW; Cawthorne MA; Coyle PJ; Holder JC; Holman GD; Kozka IJ; Kirkham DM; Lister CA; Smith SA
    Diabetes; 1995 Sep; 44(9):1087-92. PubMed ID: 7657033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic administration of BRL 26830A for 9 weeks improves insulin sensitivity but does not prevent weight gain in gold-thioglucose obese mice.
    Bryson JM; Wensley VR; Phuyal JL; Caterson ID; Cooney GJ
    Horm Metab Res; 1999 May; 31(5):317-22. PubMed ID: 10422727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diazoxide enhances adipose tissue protein kinase B activation and glucose transporter-4 expression in obese Zucker rats.
    Alemzadeh R; Zhang J; Tushaus K; Koontz J
    Med Sci Monit; 2004 Mar; 10(3):BR53-60. PubMed ID: 14976464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced content and preserved translocation of glucose transporter (GLUT 4) in white adipose tissue of obese mice.
    Machado UF; Shimizu I; Saito M
    Physiol Behav; 1994 Apr; 55(4):621-5. PubMed ID: 8190786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of diabetes and fasting on GLUT-4 (muscle/fat) glucose-transporter expression in insulin-sensitive tissues. Heterogeneous response in heart, red and white muscle.
    Camps M; Castelló A; Muñoz P; Monfar M; Testar X; Palacín M; Zorzano A
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):765-72. PubMed ID: 1554359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of adipose tissue glucose transporters in genetic obesity (fatty rat). Selective increase in the adipose cell/muscle glucose transporter (GLUT 4) expression.
    Hainault I; Guerre-Millo M; Guichard C; Lavau M
    J Clin Invest; 1991 Mar; 87(3):1127-31. PubMed ID: 1999492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-obesity and anti-diabetic actions of a beta 3-adrenoceptor agonist, BRL 26830A, in yellow KK mice.
    Yoshida T; Hiraoka N; Yoshioka K; Hasegawa G; Kondo M
    Endocrinol Jpn; 1991 Aug; 38(4):397-403. PubMed ID: 1687027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate supply for thermogenesis induced by the beta-adrenoceptor agonist BRL 26830A.
    Wilson S; Thurlby PL; Arch JR
    Can J Physiol Pharmacol; 1987 Feb; 65(2):113-9. PubMed ID: 2882828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of adipose cell size on the measurement of GLUT 4 in white adipose tissue of obese mice.
    Fabres-Machado U; Saito M
    Braz J Med Biol Res; 1995 Mar; 28(3):369-76. PubMed ID: 8520534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic effects of three weeks administration of the beta-adrenoceptor agonist BRL 26830A.
    Connacher AA; Bennet WM; Jung RT; Rennie MJ
    Int J Obes Relat Metab Disord; 1992 Sep; 16(9):685-94. PubMed ID: 1356939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity.
    Garvey WT; Maianu L; Huecksteadt TP; Birnbaum MJ; Molina JM; Ciaraldi TP
    J Clin Invest; 1991 Mar; 87(3):1072-81. PubMed ID: 1999488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defect in insulin action on expression of the muscle/adipose tissue glucose transporter gene in skeletal muscle of type 1 diabetic patients.
    Yki-Järvinen H; Vuorinen-Markkola H; Koranyi L; Bourey R; Tordjman K; Mueckler M; Permutt AM; Koivisto VA
    J Clin Endocrinol Metab; 1992 Sep; 75(3):795-9. PubMed ID: 1517369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.